The design, structural and biological characterization of a novel VEGF inhibitor peptide is described. The peptide was designed on the β5-β6 hairpin region of Placenta Growth Factor. NMR studies showed that the peptide assumes in solution a β-hairpin conformation similarly to the corresponding region of the natural ligand. In vitro experiments on endothelial cells demonstrated that the peptide is able to inhibit VEGF biological activity. This molecule represents a novel molecular entity to modulate VEGF activity and with potential application in therapy and diagnosis of angiogenesis-dependent diseases
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Angiogenesis is mainly regulated by the vascular endothelial growth factor (VEGF), a mitogen specifi...
The design, structural and biological characterization of a novel VEGF inhibitor peptide is describe...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
Angiogenesis is a fundamental process underlining physiological and pathological conditions. It is m...
Angiogenesis is a fundamental process underlining physiological and pathological conditions. It is m...
International audienceAngiogenesis is the development of a novel vascular network from a pre-existin...
The design of efficient vascular endothelial growth factor (VEGF) inhibitors is a high-priority rese...
International audiencePhysiological and pathological angiogenesis is mainly regulated by the binding...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Angiogenesis is mainly regulated by the vascular endothelial growth factor (VEGF), a mitogen specifi...
The design, structural and biological characterization of a novel VEGF inhibitor peptide is describe...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
Angiogenesis is a fundamental process underlining physiological and pathological conditions. It is m...
Angiogenesis is a fundamental process underlining physiological and pathological conditions. It is m...
International audienceAngiogenesis is the development of a novel vascular network from a pre-existin...
The design of efficient vascular endothelial growth factor (VEGF) inhibitors is a high-priority rese...
International audiencePhysiological and pathological angiogenesis is mainly regulated by the binding...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Angiogenesis is mainly regulated by the vascular endothelial growth factor (VEGF), a mitogen specifi...